BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23474352)

  • 21. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
    Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intra-fractional dosimetric analysis of image-guided intracavitary brachytherapy of cervical cancer.
    Yan J; Zhu J; Chen K; Yu L; Zhang F
    Radiat Oncol; 2021 Aug; 16(1):144. PubMed ID: 34348758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A volumetric analysis of GTV
    Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
    Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Single magnetic resonance imaging vs magnetic resonance imaging/computed tomography planning in cervical cancer brachytherapy.
    Beriwal S; Kim H; Coon D; Mogus R; Heron DE; Li X; Huq MS
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):483-7. PubMed ID: 19423307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SU-E-T-515: Comparison of Two Dose-Specification Methods for the Treatment of Uterine Cervix Cancer with HDR Brachytherapy Using a Tandem and Ring Applicator.
    Bhandare N; Yeung A
    Med Phys; 2012 Jun; 39(6Part18):3824. PubMed ID: 28518529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of DVH parameters and loading patterns of standard loading, manual and inverse optimization for intracavitary brachytherapy on a subset of tandem/ovoid cases.
    Jamema SV; Kirisits C; Mahantshetty U; Trnkova P; Deshpande DD; Shrivastava SK; Pötter R
    Radiother Oncol; 2010 Dec; 97(3):501-6. PubMed ID: 20846734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiobiological optimization comparison between pulse-dose-rate and high-dose-rate brachytherapy in patients with locally advanced cervical cancer.
    Annede P; Dumas I; Schernberg A; Tailleur A; Fumagalli I; Bockel S; Mignot F; Kissel M; Deutsch E; Haie-Meder C; Chargari C
    Brachytherapy; 2019; 18(3):370-377. PubMed ID: 30797698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes with MRI-guided image-based brachytherapy in cervical cancer: An institutional experience.
    Simha V; Rai B; Patel FD; Kapoor R; Sharma SC; Singh OA; Singla V; Dhanireddy B; Ghoshal S
    Brachytherapy; 2018; 17(2):345-351. PubMed ID: 29102740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New inverse planning technology for image-guided cervical cancer brachytherapy: description and evaluation within a clinical frame.
    Trnková P; Pötter R; Baltas D; Karabis A; Fidarova E; Dimopoulos J; Georg D; Kirisits C
    Radiother Oncol; 2009 Nov; 93(2):331-40. PubMed ID: 19846230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A feasibility study of using advanced external beam techniques to create a vaginal cuff brachytherapy-like endometrial boost plan.
    Grelewicz Z; Zerrusen B; Sathiaseelan V; Zhang H
    Med Dosim; 2018 Spring; 43(1):30-38. PubMed ID: 28886961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dosimetric comparison of 3-dimensional planning techniques using an intravaginal multichannel balloon applicator for high-dose-rate gynecologic brachytherapy.
    Park SJ; Chung M; Demanes DJ; Banerjee R; Steinberg M; Kamrava M
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):840-6. PubMed ID: 24138921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ureter dose optimization during image guided brachytherapy for cervical cancer.
    Sarwar A; Lalli N; Eminowicz G
    Brachytherapy; 2022; 21(4):397-404. PubMed ID: 35422401
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adaptive brachytherapy of cervical cancer, comparison of conventional point A and CT based individual treatment planning.
    Wanderås AD; Sundset M; Langdal I; Danielsen S; Frykholm G; Marthinsen AB
    Acta Oncol; 2012 Mar; 51(3):345-54. PubMed ID: 22035118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 45 or 50 Gy, Which is the Optimal Radiotherapy Pelvic Dose in Locally Advanced Cervical Cancer in the Perspective of Reaching Magnetic Resonance Image-guided Adaptive Brachytherapy Planning Aims?
    Mazeron R; Petit C; Rivin E; Limkin E; Dumas I; Maroun P; Annede P; Martinetti F; Seisen T; Lefkopoulos D; Chargari C; Haie-Meder C
    Clin Oncol (R Coll Radiol); 2016 Mar; 28(3):171-7. PubMed ID: 26547694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dose-volume histogram parameters of high-dose-rate brachytherapy for Stage I-II cervical cancer (≤4cm) arising from a small-sized uterus treated with a point A dose-reduced plan.
    Nakagawa A; Ohno T; Noda SE; Kubo N; Kuwako K; Saitoh J; Nakano T
    J Radiat Res; 2014 Jul; 55(4):788-93. PubMed ID: 24566721
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isodose surface volumes in cervix cancer brachytherapy: Change of practice from standard (Point A) to individualized image guided adaptive (EMBRACE I) brachytherapy.
    Serban M; Kirisits C; Pötter R; de Leeuw A; Nkiwane K; Dumas I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Marthinsen ABL; Lindegaard J; Tanderup K;
    Radiother Oncol; 2018 Dec; 129(3):567-574. PubMed ID: 30243671
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ring Versus Ovoids and Intracavitary Versus Intracavitary-Interstitial Applicators in Cervical Cancer Brachytherapy: Results From the EMBRACE I Study.
    Serban M; Kirisits C; de Leeuw A; Pötter R; Jürgenliemk-Schulz I; Nesvacil N; Swamidas J; Hudej R; Lowe G; Hellebust TP; Menon G; Oinam A; Bownes P; Oosterveld B; De Brabandere M; Koedooder K; Langeland Marthinsen AB; Whitney D; Lindegaard J; Tanderup K;
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1052-1062. PubMed ID: 32007365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of computed tomography with magnetic resonance imaging for imaging-based clinical target volume contours in cervical cancer brachytherapy.
    Zolciak-Siwinska A; Kowalczyk A; Sikorska K; Bijok M; Michalski W; Gruszczynska E
    Brachytherapy; 2018; 17(4):667-672. PubMed ID: 29764769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.